文献速递疝与腹壁外科围术期管理与 ERAS

肾移植受者腹壁疝与切口疝修补术的医院间差异

Variation of ventral and incisional hernia repairs in kidney transplant recipients.
PubMed 文献 · Surg Endosc · 2022-08-12

本研究基于2007–2018年Medicare住院理赔数据,纳入139,741例肾移植患者,评估腹壁疝或切口疝修补术(VIHR)风险的医院间差异。结果显示1年风险及信度校正后VIHR率在不同医院三分位组间差异显著,最高组修补几率是最低组的3.53倍,糖尿病和肥胖分布差异最明显。

要点

  • 肾移植后1年VIHR率在医院三分位组间从0.49%至0.98%不等。
  • 最高三分位组医院VIHR几率是最低组的3.53倍(95%CI 2.87-4.33)。
  • 糖尿病和肥胖等患者特征在医院三分位组间分布不均。

核心结论

  • 在肾移植Medicare人群中,疝修补累积发生率在医院间存在显著差异。
  • 医院三分位组间患者和医院特征不同,以糖尿病和肥胖最明显。

研究设计与样本

  • 回顾性队列研究,分析2007–2018年100%住院Medicare理赔数据。
  • 纳入139,741例肾移植患者,平均年龄51.6(SD 13.7)岁,男性84,717例(60.6%),白人72,657例(52.0%)。
  • 中位随访5.4年,2,098例(1.50%)接受VIHR。

主要发现

  • 1年风险及信度校正VIHR率:三分位1为0.49%(95%CI 0.48-0.51,范围0.31-0.59),三分位2为0.63%(95%CI 0.62-0.63,范围0.59-0.68),三分位3为0.98%(95%CI 0.91-1.05,范围0.68-2.94)。
  • 与三分位1医院相比,三分位2医院VIHR的OR为1.78(95%CI 1.37-2.31),三分位3医院OR为3.53(95%CI 2.87-4.33)。

临床怎么用

  • 临床需关注肾移植受者VIHR发生率的医院间差异,尤其糖尿病和肥胖患者。
  • 未来需探究项目及外科医生层面因素对VIHR治疗差异的影响。

局限性

  • 原文未明确报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: As survivorship following kidney transplant continues to improve, so does the probability of intervening on common surgical conditions, such as ventral or incisional hernia, in this population. Ventral hernia management is known to vary across institutions and this variation has an impact on patient outcomes. We sought to evaluate hospital level variation of ventral or incisional hernia repair (VIHR) in the kidney transplant population. METHODS: We performed a retrospective review of 100% inpatient Medicare claims to identify patients who underwent kidney transplant between 2007 and 2018. The primary outcome was 1- and 3-year ventral or incisional risk- and reliability-adjusted VIHR rates. Patient and hospital characteristics were evaluated across risk- and reliability-adjusted VIHR rate tertiles. Models were adjusted for age, sex, race, and Elixhauser comorbidities. RESULTS: Overall, 139,741 patients underwent kidney transplant during the study period with a mean age (SD) of 51.6 (13.7) years. 84,717 (60.6%) were male, and 72,657 (52.0%) were white. Median follow up time was 5.4 years. 2098 (1.50%) patients underwent VIHR. the 1 year risk- and reliability-adjusted hernia repair rates were 0.49% (95% Conf idence Interval (CI) 0.48-0.51, range 0.31-0.59) in tertile 1, 0.63% (95% CI 0.62-0.63, range 0.59-0.68) in tertile 2, and 0.98 (95% CI 0.91-1.05, range 0.68-2.94) in tertile 3. Accordingly, compared to hospitals in tertile 1, the odds of post-transplant hernia repair tertile 2 hospitals were 1.78 (95% CI 1.37-2.31) and at tertile 3 hospitals 3.53 (95% CI 2.87-4.33). CONCLUSIONS: In a large cohort of Medicare patients undergoing kidney transplant, the overall cumulative incidence of hernia repair varied substantially across hospital tertiles. Patient and hospital characteristics varied across tertile, most notably in diabetes and obesity. Future research is needed to understand if program and surgeon level factors are contributing to the observed variation in treatment of this common disease.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Solano QP, Thumma JR, Mullens C, et al. Variation of ventral and incisional hernia repairs in kidney transplant recipients. Surg Endosc. 2022. PMID: 35962230. doi:10.1007/s00464-022-09505-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。